Get Our Free Research Email
September 10-13 - The American Academy of Periodontology Annual Meeting 2016
September 14-16 - ISCoS Annual Scientific Meeting
Complete Calendar »
Jul 21 @ 4:30 PM ET - Stryker
Jul 28 @ 8:00 AM ET - Zimmer
Complete Calendar »
Private Equity Research
Focused on the Orthopedics and Dental Sector
HealthpointCapital is the leading source for research on the orthopedic and dental industry's markets, major players, technologies and trends.
The research team has created an unparalleled bank of intellectual capital that reflects a thorough understanding of the industry's dynamics,
key strategies and valuation trends. Research insights and conclusions are central to HealthpointCapital's
investment decisions. More about us...
Orthopedic & Dental Industry News
Most Recent Blog Articles Complete Archive »
IMPLANET, Life Spine, Medicrea, Safe Orthopaedics report financial results...Merit Medical Systems to acquire DFINE for $98M...Zimmer Biomet to acquire 59% stake in Medtech SA...Medtronic, NeuroPro Spinal Jaxx regulatory updates...DePuy Synthes Trauma, Medtronic, Stryker product updates...Extremity Medical, IlluminOss Medical, Mazor Robotics clinical updates more
Zimmer Biomet acquired a 59% stake in Medtech Société Anonyme, a French-based company that develops surgical robotic technologies to assist surgeons during medico-surgical interventions. The transaction values the business at an approximate enterprise value of $123.5 million, or 9.9x LTM... more
Merit Medical Systems entered into an agreement to acquire DFINE, Inc., a California-based developer of minimally invasive implant systems to treat pathologies of the vertebrae, metastatic spinal tumors, and vertebral compression fractures (VCFs). The transaction price was approximately $97.5 million,... more
Wright Medical enters divestiture agreement with Corin Orthopaedics...Cartiva regulatory update...Mazor Robotics, Spineart, Spine Wave, ulrich medical product updates...Graftys receives patent...Aurora Spine receives grant more
Wright Medical entered into an agreement to divest its hip and knee (large joint) businesses to Corin Orthopaedics for a purchase price of €29.7 million ($33 million), which values the portfolio at 0.9x 2016E revenues of $37 million and 6.0x... more
Cartiva received Premarket Approval (PMA) from the FDA for its Cartiva Synthetic Cartilage Implant (SCI) for the treatment of osteoarthritis (OA) at the base of the great toe. SCI marks the first synthetic cartilage device ever to be approved by... more
We are also a member of the Medical Device Manufacturers Association (MDMA), which champions favorable regulatory and market conditions for medical device innovators.